Načítá se...
Current therapeutic landscape for advanced gastroesophageal cancers
Treatment of advanced gastroesophageal cancers remains challenging for clinicians, patients, and caregivers alike. Despite considerable research, the therapeutic armamentarium is restricted and hardly personalized. In the first-line setting, trastuzumab with a fluoropyrimidine and platinum agent is...
Uloženo v:
| Vydáno v: | Ann Transl Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890037/ https://ncbi.nlm.nih.gov/pubmed/29666801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.10.29 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|